This is in line with the human genetic association data showing that TM6SF2 E167K carriers have higher risk not only for NAFLD but also for progression of liver damage in patients infected by viral hepatitis B and C29,30. The gene discussed is TM6SF2; the disease is metabolic dysfunction-associated steatotic liver disease.